Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies-Reference-Cited by-同舟云学术

Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies

Published:2018-07-13 Issue:7 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bala Malgorzata M¹,Paszek Elżbieta²,Lesniak Wiktoria³,Wloch-Kopec Dorota⁴,Jasinska Katarzyna⁵,Undas Anetta⁶

Affiliation:

1. Jagiellonian University Medical College; Chair of Epidemiology and Preventive Medicine; Department of Hygiene and Dietetics; Systematic Reviews Unit - Polish Cochrane Branch; Kopernika 7 Krakow Poland 31-034

2. Jagiellonian University Medical College; Department of Interventional Cardiology; Pradnicka 80 Krakow Poland

3. Jagiellonian University Medical College; 2nd Department of Internal Medicine; ul. Skawinska 8 Krakow Poland 31-066

4. Jagiellonian University Medical College; Neurology Department; Botaniczna 3 Krakow Poland 31-503

5. Jagiellonian University Medical College; Students' Research Group, Systematic Reviews Unit-Polish Cochrane Branch; Krakow Poland

6. Jagiellonian University Medical College; Institute of Cardiology; Pradnicka 80 Krakow Poland 31-202

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012534.pub2/epdf/full

Reference108 articles.

1. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipid antibody syndrome;Alalaf;Archives of Gynecology and Obstetrics,2012

2. Primary prevention of thrombosis in antiphospholipid antibodies positive patients: a prospective, multicenter, randomised, open trial comparing low dose aspirin with low dose aspirin plus low intensity oral anticoagulation;Cuadrado;Arthritis and Rheumatism,2009

3. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS);Cuadrado;Rheumatology,2014

4. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome;Dendrinos;International Journal of Gynaecology and Obstetrics,2009

5. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals;Erkan;Arthritis and Rheumatism,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dilemmas in the diagnosis and management of antiphospholipid syndrome;Journal of Thrombosis and Haemostasis;2024-08

2. Perioperative management of patients with hemostatic system disorders. Methodological recommendations of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” and the National Association of Specialists in Thrombosis, Clinical Hemostasiology and Hemorheology;Annals of Critical Care;2024-01-27

3. Risk factors of first thrombosis in obstetric antiphospholipid syndrome;Lupus Science & Medicine;2024-01

4. The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study;Journal of the Formosan Medical Association;2023-10

5. Antiphospholipid Syndrome: State of the Art of Clinical Management;Cardiovascular Drugs and Therapy;2023-08-12